Christopher Brett Primiano is EVP, CBO, GC & Secretary of Karyopharm Therapeutics Inc.. Currently has a direct ownership of 4,523 shares of KPTI, which is worth approximately $5,201. The most recent transaction as insider was on Dec 01, 2020, when has been sold 137,061 shares (Common Stock) at a price of $17.51 per share, resulting in proceeds of $2,399,938. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.52K
0% 3M change
0% 12M change
Total Value Held $5,201

Christopher Brett Primiano Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 01 2020
SELL
Open market or private sale
$2,399,938 $17.51 p/Share
137,061 Reduced 96.81%
4,523 Common Stock
Dec 01 2020
BUY
Exercise of conversion of derivative security
$1,428,176 $10.42 p/Share
137,061 Added 68.35%
63,460 Common Stock
Nov 02 2020
SELL
Open market or private sale
$11,518 $14.92 p/Share
772 Reduced 14.58%
4,523 Common Stock
Oct 13 2020
SELL
Open market or private sale
$668,785 $17.03 p/Share
39,271 Reduced 89.41%
4,649 Common Stock
Oct 13 2020
BUY
Exercise of conversion of derivative security
$384,856 $9.8 p/Share
39,271 Added 87.97%
5,370 Common Stock

Also insider at

AURA
Aura Biosciences, Inc. Healthcare
CBP

Christopher Brett Primiano

EVP, CBO, GC & Secretary
Newton, MA

Track Institutional and Insider Activities on KPTI

Follow Karyopharm Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KPTI shares.

Notify only if

Insider Trading

Get notified when an Karyopharm Therapeutics Inc. insider buys or sells KPTI shares.

Notify only if

News

Receive news related to Karyopharm Therapeutics Inc.

Track Activities on KPTI